Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue

World Journal of Gastroenterology

Volumn 10, Issue 22, 2004, Pages 3356-3360

  Zhuge, Jian ^a   Yu, Ying Nian ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 2D6; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; EXON; GENE AMPLIFICATION; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INTRON; LIVER; LIVER CELL CARCINOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 10044263283     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i22.3356     Document Type: Article

References (30)

1. Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 2002; 3: 561-597
2. Bertilsson L, Dahl ML, Dalen P, Al-Shurbaji A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 2002; 53: 111-122
3. Cascorbi I. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur J Clin Invest 2003; 33(Suppl 2): 17-22
4. Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002; 3: 229-243
5. Nissim-Rafinia M, Kerem B. Splicing regulation as a potential genetic modifier. Trends Genet 2002; 18: 123-127
6. Graveley BR. Alternative splicing: increasing diversity in the proteomic world. Trends Genet 2001; 17: 100-107
7. Maniatis T, Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 2002; 418: 236-243
8. Kriventseva EV, Koch I, Apweiler R, Vingron M, Bork P, Gelfand MS, Sunyaev S. Increase of functional diversity by alternative splicing. Trends Genet 2003; 19: 124-128
9. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336
10. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442-446
11. Huang Z, Fasco MJ, Kaminsky LS. Alternative splicing of CYP2D mRNA in human breast tissue. Arch Biochem Biophys 1997; 343: 101-108
12. Huang Z, Fasco MJ, Spivack S, Kaminsky LS. Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues. Cancer Res 1997; 57: 2589-2592
13. Woo SI, Hansen LA, Yu X, Mallory M, Masliah E. Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative disorders. Neurology 1999; 53: 1570-1572
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
15. Wu J, Dong H, Cai Z, Yu Y. Stable expression of human cytochrome CYP2B6 and CYP1A1 in Chinese hamster CHL cells: their use in micronucleus assays. Chin Med Sci J 1997; 12: 148-155
16. Qian Y, Yu Y, Cheng X, Luo J, Xie H, Shen B. Molecular events after antisense inhibition of hMSH2 in a Hela cell line. Mutat Res 1998; 418: 61-71
17. Zhuge J, Luo Y, Yu YN. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. World J Gastroenterol 2003; 9: 2732-2736
18. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 1973; 36: 32-38
19. Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet 1989; 45: 889-904
20. Judo MS, Wedel AB, Wilson C. Stimulation and suppression of PCR-mediated recombination. Nucleic Acids Res 1998; 26: 1819-1825
21. Zaphiropoulos PG. Non-homologous recombination mediated by Thermus aquaticus DNA polymerase I. Evidence supporting a copy choice mechanism. Nucleic Acids Res 1998; 26: 2843-2848
22. Shammas FV, Heikkila R, Osland A. Fluorescence-based method for measuring and determining the mechanisms of recombination in quantitative PCR. Clin Chim Acta 2001; 304: 19-28
23. Negroni M, Buc H. Mechanisms of retroviral recombination. Annu Rev Genet 2001; 35: 275-302
24. Negroni M, Buc H. Retroviral recombination: what drives the switch? Nat Rev Mol Cell Biol 2001; 2: 151-155
25. Chetverin AB. The puzzle of RNA recombination. FEBS Lett 1999; 460: 1-5
26. Zhu S, Li W, Cao ZJ. Does MMLV-RT lacking RNase H activity have the capability of switching templates during reverse transcription? FEBS Lett 2002; 520: 185
27. Burset M, Seledtsov IA, Solovyev VV. Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res 2000; 28: 4364-4375
28. Heim MH, Meyer UA. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6. Genomics 1992; 14 49-58
29. Johansson I, Oscarson M, Yue QY, Bertilsson L, Sjoqvist F, Ingelman-Sundberg M. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol 1994; 46: 452-459
30. Chida M, Ariyoshi N, Yokoi T, Nemoto N, Inaba M, Kinoshita M, Kamataki T. New allelic arrangement CYP2D6*36 × 2 found in a Japanese poor metabolizer of debrisoquine. Pharmacogenetics 2002; 12: 659-662